|4Nov 18, 4:03 PM ET

Babu Yarlagadda S 4

4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 18, 2019

Insider Transaction Report

Form 4
Period: 2019-11-18
Babu Yarlagadda S
VP Drug Discovery
Transactions
  • Purchase

    Common Stock

    2019-11-18$1.45/sh+25,000$36,250155,587 total

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT